Knight Therapeutics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acasti Pharma USD -0.36 1.85M 2024-12
Alaunos Therapeutics USD 845K 162K 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Avita Medical AUD 21.23M 2.57M 2024-12
Canopy Growth CAD 40.62M 308K 2024-12
Cronos Group USD 20.68M 130K 2024-12
Dianthus Therapeutics USD 6.83M 287K 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
IQVIA Holdings USD 453M 69M 2024-12
Knight Therapeutics CAD 25.48M 119K 2024-09
Moderna USD 212M 139M 2025-03
Organigram Holdings CAD 17.19M 2.88M 2024-12
Organon & Co USD 470M 48M 2024-12
Revvity USD 249.72M 5.9M 2025-03
Tectonic Therapeutic USD 4.84M 469K 2024-12
Tilray USD 72.38M 4.99M 2024-11
Viatris USD 882.7M 14.8M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12



Knight Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.